Home>Topics>Stocks>Ariad Pharmaceuticals

Ariad Pharmaceuticals

  1. All
  2. Headlines
  1. Sarissa Capital seeks Ariad Pharma's CEO's ouster

    Headlines

    Fri, 20 Feb 2015

    Feb 20 (Reuters) - Sarissa Capital Management LP said it was seeking the retirement of Ariad Pharmaceuticals Inc Chief Executive Harvey Berger and would nominate its founding partner to the drugmaker's board.

  2. Ariad adopts rights plan to protect tax assets

    Headlines

    Fri, 1 Nov 2013

    Nov 1 (Reuters) - Ariad Pharmaceuticals Inc adopted a shareholder rights plan to protect its tax credits, a day after sales of its flagship drug Iclusig were suspended due to safety concerns...

  3. Ariad shares fall as FDA panel fails to back cancer drug

    Headlines

    Wed, 21 Mar 2012

    (Reuters) - Ariad Pharmaceuticals ' shares fell 3 percent on Wednesday morning after a U.S. Food and Drug Administration panel did not recommend the company's experimental cancer candidate.

Content Partners